Please wait while the formulary information is being retrieved.
OMEGA MONOPURE (omega-3 fatty acids/dha/epa/dpa/fish oil)
860 mg-260 mg-1,300 mg capsule,delayed release
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- None
OMEGA MONOPURE (omega-3 fatty acids/dha/epa/dpa/fish oil)
- None
- None
More Frequent
Severe
Less Severe
- None
- Dysgeusia
- Dyspepsia
- Eructation
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Hemorrhage
- Increased alanine transaminase
- Increased aspartate transaminase
Less Severe
- Abnormal hepatic function tests
- Constipation
- Pruritus of skin
- Urticaria
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool